HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.

Abstract
Acetyl groups were introduced to the hydroxyl groups of heptakis(2, 6-di-O-methyl)-beta-cyclodextrin (DM-beta-CyD), and the resulting heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-CyD (DMA-beta-CyD) was evaluated for the inclusion property and hemolytic activity. It was confirmed by means of NMR and mass spectroscopies that in the DMA-beta-CyD molecule, all seven hydroxyl groups at the 3-position were substituted by acetyl groups. Thus, it has the degree of substitution (DS) of 7, whereas DMA4-beta-CyD with the lower substitution (DS 3.8) was a mixture of components with different DS. The aqueous solubility of DMA-beta-CyD was higher than those of beta-CyD, DM-beta-CyD, and heptakis(2,3,6-tri-O-methyl)-beta-CyD (TM-beta-CyD). The hydrophobicity of the whole molecule, assessed from measurements of surface tension, increased in the order of DM-beta-CyD < DMA-beta-CyD < TM-beta-CyD. The half-life of DMA-beta-CyD for hydrolysis in pH 9.5 and 60 degrees C was about 19 h, and there was only slight liberation of acetic acid in rabbit plasma and carboxylesterase (EC 3.1.1.1) at 37 degrees C. DMA-beta-CyD had an inclusion ability similar to that of TM-beta-CyD for p-hydroxybenzoic acid esters with different alkyl chain lengths and an antiinflammatory drug, flurbiprofen, although it was inferior to that of DM-beta-CyD. The hemolytic activity and rabbit muscular irritation of DMA-beta-CyDs were much weaker than those of DM-beta-CyD: no hemolysis was observed even in the presence of 0.1 M DMA-beta-CyD with DS 7. The results suggest that the water-soluble CyD derivative with superior bioadaptability and inclusion ability can be prepared by properly designing substituents at the 3-position and by optimally controlling their degree of substitution.
AuthorsF Hirayama, S Mieda, Y Miyamoto, H Arima, K Uekama
JournalJournal of pharmaceutical sciences (J Pharm Sci) Vol. 88 Issue 10 Pg. 970-5 (Oct 1999) ISSN: 0022-3549 [Print] United States
PMID10514341 (Publication Type: Journal Article)
Chemical References
  • Cyclodextrins
  • Excipients
  • Irritants
  • beta-Cyclodextrins
  • heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin
  • Cholesterol
Topics
  • Animals
  • Chemical Phenomena
  • Chemistry, Physical
  • Cholesterol (blood)
  • Cyclodextrins (chemical synthesis, toxicity)
  • Erythrocytes (drug effects)
  • Excipients (chemical synthesis, toxicity)
  • Hemolysis (drug effects)
  • Hydrolysis
  • In Vitro Techniques
  • Irritants (toxicity)
  • Muscular Diseases (chemically induced, pathology)
  • Rabbits
  • Solubility
  • Spectrometry, Fluorescence
  • beta-Cyclodextrins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: